🔎 Trials Near Me

Dachaigh › Aillse Sgamhain Neo-chealla-beag › Montana

Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Montana

Tha 18 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann an Montana.

Bailtean ann an Montana

Teacsa sgrùdaidh oifigeil (Beurla)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04267848

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  • Billings Clinic ( Site 3255), Billings
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07513376

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • Benefis Sletten Cancer Institute, Great Falls
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07388524

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Saint Vincent Frontier Cancer Center, Billings
  • agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • St. Vincent Frontier Cancer Center, Billings
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06881784

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana, Billings
  • Bozeman Health Deaconess Hospital - Bozeman Health Cancer Center, Bozeman
  • Bozeman Health Deaconess Hospital - Bozeman Health Clinical Research, Bozeman
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07144280

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • SCL Health - Montana, Billings
  • SCL Health - Montana, Billings
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • agus 6 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT03191149

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

  • Logan Health Research, Kalispell
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06899126

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  • St. Vincent Frontier Cancer Center-Research ( Site 0105), Billings
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06345729

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  • St. Vincent Frontier Cancer Center, Billings
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07288177

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Intermountain Health - St. Vincent Frontier Cancer Center, Billings
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06162221

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • agus 3 a bharrachd
A’ fastadhÌre 2
18 Minutes · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • agus 3 a bharrachd
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Montana Cancer Consortium NCORP, Billings
  • agus 5 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Billings
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.